Form4insider filings, from the source

SEC Form 4 · accession 0001179110-17-014171

BeOne Medicines Ltd. · ONC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John Oyler
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Nov 13, 2017
Accepted (ET)
Nov 15, 2017 · 8:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
American Depositary SharesF1,F3Nov 13, 2017S8,109$82.6706D491,891D
American Depositary SharesF1,F4Nov 13, 2017S16,845$83.2375D475,046D
American Depositary SharesF1Nov 13, 2017S100$84.04D474,946D
American Depositary SharesF1,F5Nov 14, 2017S39,328$79.5451D435,618D
American Depositary SharesF1,F6Nov 14, 2017S20,407$80.0951D415,211D
American Depositary SharesF1Nov 14, 2017S100$81.00D415,111D
American Depositary SharesF1,F11Nov 15, 2017S3,798$79.1556D411,313D
American Depositary SharesF1,F12Nov 15, 2017S62,170$80.2926D349,143D
American Depositary SharesF1Nov 15, 2017S100$80.84D349,043D
Ordinary Sharesholding———15,245,525D
Ordinary SharesF7holding———29,890,174ISee Footnote
Ordinary SharesF8holding———10,000,000ISee Footnote
Ordinary SharesF9holding———102,188ISee Footnote
Ordinary SharesF10holding———7,962,663ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses